NEVVI Medicare utilization intelligence
or

← back

Provider profile

BYRD, VICTOR M.D.

Rheumatology · NPI 1952392797 · NASHVILLE, TN

2
Groups
35
Codes · 2024
96,161
Disclosed services

BYRD, VICTOR is a Rheumatology in NASHVILLE, TN, a member of 2 medical groups, who billed 35 distinct codes to Medicare Part B in 2024.

Groups: HERITAGE MEDICAL ASSOCIATES PC (NASHVILLE, TN) · SELECT PHYSICAL THERAPY HOLDINGS INC (EAGLE RIVER, AK) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

96,161
disclosed services
35
codes billed to Medicare Part B
Prior year · CY2023 96,215 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1602 Injection, golimumab, 1 mg, for intravenous use
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1010 Injection, methylprednisolone acetate, 1 mg
J0897 Injection, denosumab, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2919 Injection, methylprednisolone sodium succinate, 5 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
77080 Dxa bone density measurement of hip, pelvis, spine
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96413 Administration of chemotherapy into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
86140 Measurement c-reactive protein for detection of infection or inflammation
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
85652 Red blood cell sedimentation rate, to detect inflammation, automated
96415 Administration of chemotherapy into vein, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96374 Injection of drug or substance into vein
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96375 Injection of additional new drug or substance into vein
J1030 Injection, methylprednisolone acetate, 40 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
86431 Rheumatoid factor level
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
81001 Manual urinalysis test with examination using microscope, automated
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
84550 Uric acid level, blood
82550 Creatine kinase (cardiac enzyme) level, total
84443 Blood test, thyroid stimulating hormone (tsh)
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.